Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas. - Full text - MIT Libraries
MI Patrikis, EJ Bryan, NA Thomas, GE Rice, MA … - Mol Carcinog, 2003 - doi.wiley.com
... 63 Page 4. and CUTL1 family members. Oncogene 1998;16:1963– 1972. 10. ... MDM2 over-
expression is rare in ovarian carcinoma irrespective of TP53 mutation status. ...
Cited by 1 - Web Search - ncbi.nlm.nih.gov - ncbi.nlm.nih.gov

Molecular Characterization of Diffuse Large B-cell Lymphoma and Aspects of Transformation
M BERGLUND - diva-portal.org
... death such as TP53 and RB1. Inactivation of such genes is rate-limiting for ... P53 TP53
is probably the most frequently mutated gene in human cancer and has ...
Web Search - publications.uu.se

Pooled Analysis of Loss of Heterozygosity in Breast Cancer: a Genome Scan Provides Comparative … - Full text - MIT Libraries
BJ Miller, D Wang, R Krahe, FA Wright - The American Journal of Human Genetics, 2003 - journals.uchicago.edu
... density plot of informative observations (above the scatterplot) shows that the
data are concentrated at 17pter and the regions containing TP53 and BRCA1. ...
Cited by 6 - Web Search - journals.uchicago.edu - ncbi.nlm.nih.gov

Bibliography Current World Literature
GP Adams, PJ Carder, S Downey, MA Forbes, K Mac- … - Current Opinion in Oncology, 2001 - co-oncology.com
... Berns EMJJ, Vanstaveren IL, Look MP, Smid M, Klijn JGM, Foekens JA: Mutations in
residues of TP53 that directly contact DNA predict poor outcome in human ...
Web Search - co-cardiology.com - co-pediatrics.com - co-ophthalmology.com - all 6 versions »